文献速递乳腺技术与安全乳腺X线

新型图像处理算法降低分子乳腺成像剂量

Dose Reduction in Molecular Breast Imaging With a New Image-Processing Algorithm.
PubMed 文献 · AJR Am J Roentgenol · 2019-10-08

本研究分析50例受试者的标准剂量分子乳腺成像(300 MBq 99mTc-sestamibi)图像,通过动态帧叠加模拟半剂量并用专有算法处理(默认与优选滤波模式),由两名乳腺放射科医师独立完成二选一强制选择任务。结果显示,优选滤波的半剂量图像在病灶显著性上等效或优于标准剂量图像,且不损害图像质量。

要点

  • 优选滤波模式处理的半剂量图像在病灶显著性上等效或优于标准剂量图像。
  • 半剂量图像未处理时病灶显著性较标准剂量差。
  • 算法可降低注射活度,也可能缩短成像时间并提高患者舒适度与检查通量。

核心结论

  • 与标准剂量图像相比,经算法处理并以标准剂量一半采集的图像在病灶显著性上等效或更好,且不损害图像质量;该算法也可用于缩短成像时间,从而提高患者舒适度和检查通量。

研究设计与样本

  • 研究分析50例受试者的标准剂量分子乳腺成像(300 MBq 99mTc-sestamibi)动态图像;通过叠加一半动态帧模拟半剂量检查,并用专有图像处理算法分别以默认滤波和优选滤波模式处理;由两名乳腺放射科医师独立完成二选一强制选择任务,比较标准剂量、半剂量及算法处理后半剂量图像的病灶显著性。

诊断标准与关键数值

  • 相对于标准剂量图像,半剂量图像在100次判读中被偏好4次,默认滤波半剂量图像被偏好50次,优选滤波半剂量图像被偏好76次。
  • 与标准剂量图像相比,半剂量图像病灶显著性被评为更好2次、等效6次、更差92次(共100次判读)。
  • 默认滤波半剂量图像病灶显著性被评为更好13次、等效73次、更差14次(共100次判读)。
  • 优选滤波半剂量图像病灶显著性被评为更好55次、等效34次、更差11次(共100次判读)。

临床应用与阅片要点

  • 在分子乳腺成像中,可考虑使用该图像处理算法以半剂量采集并保持病灶显著性。
  • 该算法也可用于缩短成像时间,从而提高患者舒适度和检查通量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purpose of this study was to determine whether application of a proprietary image-processing algorithm would allow a reduction in the necessary administered activity for molecular breast imaging (MBI) examinations. MATERIALS AND METHODS. Images from standard-dose MBI examinations (300 MBq 99mTc-sestamibi) of 50 subjects were analyzed. The images were acquired in dynamic mode and showed at least one breast lesion. Half-dose MBI examinations were simulated by summing one-half of the dynamic frames and were processed with the algorithm under study in both a default and a preferred filter mode. Two breast radiologists independently completed a set of two-alternative forced-choice tasks to compare lesion conspicuity on standard-dose images, half-dose images, and the algorithm-processed half-dose images in both modes. RESULTS. Relative to the standard-dose images, the half-dose images were preferred in 4, the default-filtered half-dose images in 50, and preferred-filtered half-dose images in 76 of 100 readings. Compared with standard-dose images, in terms of lesion conspicuity, the half-dose images were rated better in 2, equivalent in 6, and poorer in 92 of 100 readings. The default-filtered half-dose images were rated better, equivalent, or poorer in 13, 73, and 14 of 100 readings. The preferred-filtered half-dose images were rated as better, equivalent, or poorer in 55, 34, and 11 of 100 readings. CONCLUSION. Compared with that on standard-dose images, lesion conspicuity on images obtained with the algorithm and acquired at one-half the standard dose was equivalent or better without compromise of image quality. The algorithm can also be used to decrease imaging time with a resulting increase in patient comfort and throughput.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Tao AT, Hruska CB, Conners AL, et al. Dose Reduction in Molecular Breast Imaging With a New Image-Processing Algorithm. AJR Am J Roentgenol. 2019. PMID: 31593516. doi:10.2214/AJR.19.21582

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。